Cargando…

Discharge of Acute Coronary Syndrome Patients on Sub-Optimal Dual Anti-Platelet Therapy: A Single Center Experience

PURPOSE: To identify and quantify the reasons why acute coronary syndrome (ACS) patients undergoing stenting at University of New Mexico Hospital were prescribed sub-optimal dual antiplatelet therapy (DAPT) at discharge, and to identify practice patterns that could potentially lead to improved DAPT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Booker, Jeffrey, Nihart, alexander, Campen, matthew, Medrano-Rodriguez, Eduardo, Blankenship, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602150/ https://www.ncbi.nlm.nih.gov/pubmed/37886454 http://dx.doi.org/10.21203/rs.3.rs-3425525/v1

Ejemplares similares

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Jäger, Bernhard, et al.
Publicado: (2018)

Preoperative Cessation of Both Dual Anti-Platelet Agents Is Safe after 1 Year in Patients Receiving Percutaneous Coronary Intervention
por: Lee, Jeen Hwa, et al.
Publicado: (2020)

Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis
por: Long, Manyun, et al.
Publicado: (2020)

The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease
por: Chen, Shi-Jian, et al.
Publicado: (2017)

Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome: A meta-analysis
por: Jin, Jing, et al.
Publicado: (2021)

In-hospital major bleeding in patients with acute coronary syndrome medically treated with dual anti-platelet therapy: Associated factors and impact on mortality
por: Sun, Yihong, et al.
Publicado: (2022)

Barriers to Early Discharge after Elective Percutaneous Coronary Intervention (BED PCI): A Single-Center Study
por: Graziano, Francis D., et al.
Publicado: (2017)

Optimal duration of dual antiplatelet therapy for coronary artery disease
por: Kikkert, W. J., et al.
Publicado: (2018)

Spontaneous Huge Subdural Spine Hematoma in a Patient Receiving Dual Anti-platelet Therapy after Drug-eluting Coronary Stent Implantation
por: Han, Xiongyi, et al.
Publicado: (2018)

Electron Information in Single- and Dual-Frequency Capacitive Discharges at Atmospheric Pressure
por: Park, Sanghoo, et al.
Publicado: (2018)

Cancer Survivors with Sub-Optimal Patient-Centered Communication Before and During the Early COVID-19 Pandemic.
por: Kim, Jiyeong, et al.
Publicado: (2023)

Right middle cerebral artery aneurysm posted for clipping on dual anti-platelet therapy
por: Parida, Satyen, et al.
Publicado: (2010)

Spontaneous hematoma in the setting of dual anti-platelet therapy with ticagrelor: A case report
por: FENG, CHUNGUANG, et al.
Publicado: (2016)

Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI
por: Zhang, Lijie, et al.
Publicado: (2022)

Successful administration of unilateral spinal anaesthesia in a patient receiving dual anti-platelet therapy under platelet transfusion cover
por: Arya, Abhishek, et al.
Publicado: (2022)

Improving Early Discharges With an Electronic Health Record Discharge Optimization Tool
por: Perry, Michael F., et al.
Publicado: (2020)

Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome
por: Scudiero, Fernando, et al.
Publicado: (2020)

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention
por: Wang, Jing, et al.
Publicado: (2021)

It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent
por: Kim, Ju-Youn, et al.
Publicado: (2015)

Optimism pervades Parkinson's conference.
por: Booker, S M
Publicado: (2001)

High-Intensity Exercise Training Improves Basal Platelet Prostacyclin Sensitivity and Potentiates the Response to Dual Anti-Platelet Therapy in Postmenopausal Women
por: Wickham, Kate A., et al.
Publicado: (2022)

Coronary Artery Bypass Surgery, Angioplasty and Long Term Anti-Platelet Treatment in a Type B Hemophilia Patient
por: Pesaro, Antonio Eduardo, et al.
Publicado: (2009)

Optimal dual antiplatelet therapy strategy in elderly patients with acute coronary syndrome
por: Verdoia, Monica, et al.
Publicado: (2021)

NTP center reports on phthalate concerns.
por: Booker, S M
Publicado: (2001)

Optimization of Heart Failure Patients Discharge Plan in Rajaie Cardiovascular Medical and Research Center: An Action Research
por: Shabani, Fidan, et al.
Publicado: (2021)

Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome
por: Tatarunas, Vacis, et al.
Publicado: (2020)

Novel Patient‐Centered Approach to Facilitate Same‐Day Discharge in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Amin, Amit P., et al.
Publicado: (2018)

Discharging Preterm Infants Home on Caffeine, a Single Center Experience
por: Ma, Cheng, et al.
Publicado: (2020)

Impact of Platelet Transfusion on Survival of Patients with Intracerebral Hemorrhage after Administration of Anti-Platelet Agents at a Tertiary Emergency Center
por: Suzuki, Yuhko, et al.
Publicado: (2014)

Recurrent Stent Thrombosis in a Patient with Antiphospholipid Syndrome and Dual Anti-Platelet Therapy Non-Responsiveness
por: Lee, You-Hong, et al.
Publicado: (2015)

Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?
por: Abbas, Hafsa, et al.
Publicado: (2020)

Dual anti-platelet therapy for secondary prevention in intracranial atherosclerotic disease: a network meta-analysis
por: Reale, Giuseppe, et al.
Publicado: (2022)

183. Optimization of an Outpatient Antimicrobial Stewardship Process for Patients Discharged from the Emergency Department at an Academic Medical Center
por: Kafisheh, Hannah, et al.
Publicado: (2020)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015)

Impact of Obstructive Sleep Apnea on Platelet Function Profiles in Patients With Acute Coronary Syndrome Taking Dual Antiplatelet Therapy
por: Gong, Wei, et al.
Publicado: (2018)

Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
por: Charif, Fida, et al.
Publicado: (2019)

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
por: Dragovich, Tomislav, et al.
Publicado: (2009)

A Mechanism for Stroke Complicating Coronary Thrombus Aspiration
por: Riangwiwat, Tanawan, et al.
Publicado: (2020)

De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
por: Han, Ya-Ling
Publicado: (2019)

POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience
por: Simion, Chiara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kek601n4nn5ep9vqu3r6najij1